We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$13.5B
AUM Growth
-$537M
Cap. Flow
-$203M
Cap. Flow %
-1.51%
Top 10 Hldgs %
19.68%
Holding
385
New
13
Increased
113
Reduced
185
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.3M
2
QCOM icon
Qualcomm
QCOM
+$36.9M
3
ATKR icon
Atkore
ATKR
+$27.5M
4
WTRG icon
Essential Utilities
WTRG
+$26.1M
5
HALO icon
Halozyme
HALO
+$19.4M

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$43.2M
2
CPE
Callon Petroleum Company
CPE
+$35.4M
3
UMBF icon
UMB Financial
UMBF
+$31M
4
SLB icon
SLB Ltd
SLB
+$30.8M
5
JPM icon
JPMorgan Chase
JPM
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Financials 14.32%
3 Healthcare 14.05%
4 Industrials 13.81%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
226
Ecolab
ECL
$77B
$4.53M 0.03%
19,029
-90
-0.5% -$20.8K
ABBV icon
227
AbbVie
ABBV
$465B
$4.42M 0.03%
25,756
+18
+0.1% +$2.98K
AZPN
228
DELISTED
Aspen Technology Inc
AZPN
$4.31M 0.03%
21,709
+380
+2% +$78.1K
VTI icon
229
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$4.04M 0.03%
15,113
AVGO icon
230
Broadcom
AVGO
$1.62T
$3.92M 0.03%
24,430
-250
-1% -$35K
SPY icon
231
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$3.91M 0.03%
7,191
-24
-0.3% -$12.6K
DEO icon
232
Diageo
DEO
$48.3B
$3.65M 0.03%
28,986
-2,440
-8% -$336K
HON icon
233
Honeywell
HON
$64.5B
$3.31M 0.02%
16,444
-639
-4% -$122K
MCO icon
234
Moody's
MCO
$80.9B
$3.19M 0.02%
7,575
-55
-0.7% -$21.9K
LLY icon
235
Eli Lilly
LLY
$1.01T
$3.02M 0.02%
3,333
-108
-3% -$86.4K
MA icon
236
Mastercard
MA
$502B
$2.71M 0.02%
6,154
-235
-4% -$107K
UNF icon
237
Unifirst Corp
UNF
$4.83B
$2.69M 0.02%
15,710
-124,119
-89% -$20M
IWD icon
238
iShares Russell 1000 Value ETF
IWD
$82.8B
$2.59M 0.02%
14,849
KO icon
239
Coca-Cola
KO
$382B
$2.47M 0.02%
38,793
-1,219
-3% -$75.5K
LIN icon
240
Linde
LIN
$213B
$2.43M 0.02%
5,549
-12,121
-69% -$5.33M
CMG icon
241
Chipotle Mexican Grill
CMG
$44.1B
$2.42M 0.02%
38,600
-150
-0.4% -$9.32K
VLTO icon
242
Veralto
VLTO
$23.3B
$2.35M 0.02%
24,586
+186
+0.8% +$17.8K
VRSK icon
243
Verisk Analytics
VRSK
$23.4B
$2.2M 0.02%
8,150
-46
-0.6% -$11.3K
NEE icon
244
NextEra Energy
NEE
$169B
$2.17M 0.02%
30,590
INTU icon
245
Intuit
INTU
$88B
$2.03M 0.02%
3,091
-70
-2% -$43.4K
PFE icon
246
Pfizer
PFE
$157B
$2.03M 0.02%
72,582
-2,997
-4% -$82.5K
MMM icon
247
3M
MMM
$84.9B
$1.99M 0.01%
19,450
-4,649
-19% -$453K
DSI icon
248
iShares MSCI KLD 400 Social ETF
DSI
$5.39B
$1.98M 0.01%
19,097
VV icon
249
Vanguard Morningstar Large-Cap ETF
VV
$53.7B
$1.91M 0.01%
7,645
INTC icon
250
Intel
INTC
$513B
$1.89M 0.01%
61,003
-2,300
-4% -$75.4K

Similar funds

Boston Trust Walden's Q2 2024 Portfolio in Review

As of Q2 2024, Boston Trust Walden held 385 positions worth $13.5B, down 3.8% from $14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2024 filing shows 13 new, 113 increased, 185 reduced and 7 closed positions. Its largest new stake was Atkore: 172,729 shares worth $23.3M. The largest sale was Medpace, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2024 buy was Atkore: 172,729 shares worth $23.3M.
  • Boston Trust Walden added most to NVIDIA in Q2 2024, an estimated $46.3M increase.
  • Boston Trust Walden's biggest Q2 2024 reduction was Medpace, cutting an estimated $43.2M.
  • Boston Trust Walden fully exited Callon Petroleum Company in Q2 2024, selling an estimated $35.4M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $13.5B portfolio in Q2 2024.
  • Boston Trust Walden opened 13 new positions and closed 7 in Q2 2024.
  • Boston Trust Walden's portfolio value fell 3.8% quarter-over-quarter to $13.5B.

Based on Boston Trust Walden's 13F filing for Q2 2024, filed 19 Jul 2024.